|
- 2016
免疫性疾病患者T-SPOT.TB筛查结果及影响因素
|
Abstract:
[1] | 梁旗, 李鸿斌, 赵静. 酶联免疫斑点技术在风湿病患者结核诊断中的应用[J]. 中华风湿病杂志, 2009, 13(8): 578-580. |
[2] | QIU Haomin, ZHANG Shu, XUE Yu, et al. Use of an enzyme-linked immunospot assay for diagnosing latent tuberculosis infection in rheumatic diseases[J]. Chin J Rheumatol, 2010, 14(5): 301-304. |
[3] | Vadillo Font C, Hernández-García C, Pato E, et al. Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases[J]. Rev Clin Esp, 2003, 203(4): 178-182. |
[4] | Askling J, Fored CM, Brandt L, et al. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden[J]. Arthritis Rheum, 2005, 52(7): 1986-1992. |
[5] | He D, Bai F, Zhang S, et al. High incidence of tuberculosis infection in rheumatic diseases and impact for chemoprophylactic prevention of tuberculosis activation during biologics therapy[J]. Clin Vaccine Immunol, 2013, 20(6): 842-847. |
[6] | Beglinger C, Dudler J, Mottet C, et al. Screening for tuberculosis infection before the initiation of anti-TNF-alpha therapy[J]. Swiss Med Wkly, 2007, 137(43-44): 620-622. |
[7] | Wolfe F, Michaud K, Anderson J, et al. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy[J]. Arthritis Rheum, 2004, 50(2): 372-379. |
[8] | Person AK, Pettit AC, Sterling TR. Diagnosis and treatment of latent tuberculosis infection: an update[J]. Curr Respir Care Rep, 2013, 2(4): 199-207. |
[9] | 吴妹英, 王霞芳, 肖玉梅, 等. 酶联免疫斑点法在快速诊断活动性肺结核中的应用[J]. 中华实验和临床感染病杂志(电子版), 2009, 3(2): 1-4. |
[10] | Murakami S, Takeno M, Kirino Y, et al. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis[J]. Tuberculosis(Edinb), 2009, 89(2): 136-141. |
[11] | Xie X, Chen JW, Li F, et al. A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy[J]. Clin Exp Med, 2011, 11(3): 155-161. |